(Q28166312)

https://api.crossref.org/works/10.1080/07853890310017053

Angiogenesis in cancer and other diseases

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

Sulindac inhibits activation of the NF-kappaB pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/07853890310017053

21 April 2017

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Role of angiogenesis in tumor growth and metastasis

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

From studies of biochemical mechanism to novel biological mediators: Prostaglandin endoperoxides, thromboxanes, and leukotriences

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Nonsteroidal anti-inflammatory drugs and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

The prevention of colorectal cancer by aspirin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Breast cancer and NSAID use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Identification of a phorbol ester-repressible v-src-inducible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Host cyclooxygenase-2 modulates carcinoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Adhesion events in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Rac regulates vascular endothelial growth factor stimulated motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

A dominant-negative p65 PAK peptide inhibits angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Role of BAX in the apoptotic response to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

COX-2 inhibitors in cancer treatment and prevention, a recent development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogen-activated protein kinase in articular chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Imaging of angiogenesis: from microscope to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase-2--specific inhibitors: are they safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase inhibitors--current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Meloxicam inhibits the growth of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

Effect of ibuprofen on tumor growth in the C6 spheroid implantation glioma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053

COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310017053